President Trump recently moved to expedite research and increase access to some psychedelic substances for the treatment of serious mental health disorders.
In this new Q&A, RAND's Beau Kilmer discusses the evidence on psychedelic use and policy.
As AI systems assume more decisionmaking roles in government, the economy, and society, a question emerges: Will humans retain the capacity to shape collective outcomes?